Medical Xpress January 24, 2022
Massachusetts Institute of Technology

The COVID-19 pandemic sent shockwaves through the life science ecosystem, uniting the scientific community with a common purpose and reimagining pathways to address global health challenges.

To help accelerate that innovation, the MIT Center for Collective Intelligence, the MIT Media Lab’s Community Biotechnology Initiative, and MilliporeSigma—the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany—together convened more than 200 thought leaders from around the world to collaboratively capture the disruptions caused by the , and identify the solutions that will help usher in the future of the life sciences.

A comprehensive report containing synthesized, data-driven insights from this expert group, known as the “Life Sciences Supermind,” has now been published. The work builds on the collaborators’ research from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article